<SEC-DOCUMENT>0000930413-23-001200.txt : 20230406
<SEC-HEADER>0000930413-23-001200.hdr.sgml : 20230406
<ACCEPTANCE-DATETIME>20230406161108
ACCESSION NUMBER:		0000930413-23-001200
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230406
DATE AS OF CHANGE:		20230406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		23806284

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>c105212_defa14a.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="border-bottom: rgb(51,51,51) thick solid; vertical-align: top; text-align: left">
  <TD></TD></TR>

<TR STYLE="border-bottom: rgb(51,51,51) thin solid; vertical-align: top; text-align: left">
  <TD STYLE="width: 100%"></TD></TR>
</TABLE>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 8pt 0 12pt; text-align: center">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">SCHEDULE 14A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">Proxy Statement Pursuant to Section 14(a) of
the<BR>
Securities Exchange Act of 1934 (Amendment No. )</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Filed by the Registrant [X]<BR>
Filed by a Party other than the Registrant [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.65pt; padding-left: 5.65pt"><FONT STYLE="font-size: 10pt">[_]</FONT></TD>
    <TD STYLE="padding-right: 5.65pt; padding-left: 5.65pt"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.65pt; padding-left: 5.65pt"><FONT STYLE="font-size: 10pt">[_]</FONT></TD>
    <TD STYLE="padding-right: 5.65pt; padding-left: 5.65pt"><FONT STYLE="font-size: 10pt">CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (as permitted by Rule 14a-6(e)(2))</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.65pt; padding-left: 5.65pt"><FONT STYLE="font-size: 10pt">[_]</FONT></TD>
    <TD STYLE="padding-right: 5.65pt; padding-left: 5.65pt"><FONT STYLE="font-size: 10pt">Definitive Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.65pt; padding-left: 5.65pt"><FONT STYLE="font-size: 10pt">[X]</FONT></TD>
    <TD STYLE="padding-right: 5.65pt; padding-left: 5.65pt"><FONT STYLE="font-size: 10pt">Definitive Additional Materials</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.65pt; padding-left: 5.65pt"><FONT STYLE="font-size: 10pt">[_]</FONT></TD>
    <TD STYLE="padding-right: 5.65pt; padding-left: 5.65pt"><FONT STYLE="font-size: 10pt">Soliciting Material Pursuant to Section 240.14a-12</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">Quest Diagnostics Incorporated</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">(Name of Registrant as Specified In Its Charter) </FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0">Payment of Filing Fee (Check the appropriate box):</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-size: 10pt">[X]</FONT></TD>
    <TD STYLE="width: 97%"><FONT STYLE="font-size: 10pt">&nbsp;No fee required</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 10pt">[_]</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;Fee paid previously with preliminary materials</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">[_]</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="border-bottom: rgb(51,51,51) thin solid; vertical-align: top; text-align: left">
  <TD STYLE="width: 100%"></TD></TR>
<TR STYLE="border-bottom: rgb(51,51,51) thick solid; vertical-align: top; text-align: left">
  <TD></TD></TR>
</TABLE>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 50%"><PAGE></PAGE></TD><TD STYLE="text-align: right; width: 50%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.98pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><IMG SRC="x1_c105212x2x1.jpg" ALT=""></P>

<P STYLE="font: 10.98pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10.98pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>IMPORTANT NOTICE REGARDING THE AVAILABILITY
OF PROXY MATERIALS FOR THE QUEST</B></P>

<P STYLE="font: 10.98pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><B>DIAGNOSTICS INCORPORATED ANNUAL MEETING
OF STOCKHOLDERS TO BE HELD ON MAY 17, 2023</B></P>

<P STYLE="font: 10.98pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10.98pt Arial, Helvetica, Sans-Serif; margin-top: 0; text-align: center; margin-bottom: 0"><B>Notice of Annual Meeting of Stockholders</B></P>

<P STYLE="font: 9.48pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 9.48pt Arial, Helvetica, Sans-Serif; margin: 0"><B>WHEN AND WHERE IS THE STOCKHOLDERS MEETING?</B></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The 2023 Annual Meeting of Stockholders of Quest Diagnostics
Incorporated will be held at One Insights Drive, Clifton, New Jersey, on Wednesday, May 17, 2023, at 10:30 a.m. local time. If
you need directions to the Annual Meeting, please call 1-973-520-2900.</P>

<P STYLE="font: 9.48pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 9.48pt Arial, Helvetica, Sans-Serif; margin: 0"><B>WHAT IS BEING VOTED ON AT THE STOCKHOLDERS MEETING?</B></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt">&nbsp;</TD>
    <TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD>
    <TD STYLE="text-align: justify">the election of ten director nominees named in the proxy statement;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&#183;</FONT></TD>
    <TD STYLE="text-align: justify">an advisory resolution to approve the executive officer compensation disclosed in the Company&rsquo;s 2023 proxy statement;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&#183;</FONT></TD>
    <TD STYLE="text-align: justify">an advisory vote to recommend the frequency of the stockholder advisory vote to approve executive officer compensation;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&#183;</FONT></TD>
    <TD STYLE="text-align: justify">ratification of the appointment of our independent registered public accounting firm for 2023;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&#183;</FONT></TD>
    <TD STYLE="text-align: justify">approval of the Amended and Restated Employee Long-Term Incentive Plan;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&#183;</FONT></TD>
    <TD STYLE="text-align: justify">a stockholder proposal regarding a report on the Company&rsquo;s greenhouse gas emissions, if properly presented; and</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&#183;</FONT></TD>
    <TD STYLE="text-align: justify">such other business as may properly come before the meeting or any adjournment or postponement thereof.</TD></TR>
</TABLE>
<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 9.48pt Arial, Helvetica, Sans-Serif; margin: 0"><B>WHAT DOES THE BOARD OF DIRECTORS RECOMMEND?</B></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Quest Diagnostics Board of Directors recommends you vote
FOR the election of the ten directors, FOR the advisory resolution to approve the executive officer compensation disclosed in the
Company&rsquo;s 2023 proxy statement, 1 YEAR on the advisory vote to recommend the frequency of the stockholder advisory vote to
approve executive officer compensation, FOR ratification of the appointment of our independent registered public accounting firm
for 2023, FOR approval of the Amended and Restated Employee Long-Term Incentive Plan, and AGAINST the stockholder proposal regarding
a report on the Company&rsquo;s greenhouse gas emissions.</P>

<P STYLE="font: 9.48pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 9.48pt Arial, Helvetica, Sans-Serif; margin: 0"><B>HOW CAN I GET A COMPLETE SET OF PROXY MATERIALS?</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10.02pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B><I><U>This is not a proxy card. If you wish to submit your
proxy on a traditional proxy card, you must request a paper copy of the proxy materials by following the instructions below.</U></I></B></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>This communication presents only an overview of the more
complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important
information contained in the proxy materials before voting.</B></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><B>The following documents are available at: <U>www.ViewMaterial.com/DGX</U></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 27pt">&nbsp;</TD>
    <TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD>
    <TD><B>2023 Proxy Statement</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Symbol">&#183;</FONT></TD>
    <TD><B>2022 Annual Report</B></TD></TR>
</TABLE>
<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B>If you want to receive a paper or e-mail copy of these documents,
you must request one; otherwise you will not receive a paper or e-mail copy. There is no charge to you for requesting a copy. Please
make your request for a copy as instructed below on or before May 3, 2023, to facilitate timely delivery.</B></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">You may request a paper or e-mail copy of the proxy materials
by following the instructions below. You will be asked to provide the 11-digit control number (located by the arrow in the box
below).</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18pt; padding-bottom: 5pt">&nbsp;</TD>
    <TD STYLE="width: 18pt; padding-bottom: 5pt">1.</TD>
    <TD STYLE="padding-bottom: 5pt; text-align: justify">Call the toll-free telephone number 1-800-516-1564 and follow the instructions provided, or</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 5pt">2.</TD>
    <TD STYLE="padding-bottom: 5pt; text-align: justify">Access the website, <U>www.SendMaterial.com</U> and follow the instructions provided, or</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>3.</TD>
    <TD STYLE="text-align: justify">Send an e-mail to <U>papercopy@SendMaterial.com </U>with your control number in the Subject line. Unless you instruct
    otherwise, we will reply to your e-mail with links to the proxy materials in PDF format for this meeting only.</TD></TR>
</TABLE>
<P STYLE="font: 10.98pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 9pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 70%; padding: 5pt">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 5%; border-top: Black 3px double; border-bottom: Black 3px double; border-left: Black 3px double; font: 14pt Wingdings; padding: 5pt">&egrave;</TD>
    <TD STYLE="width: 20%; border-top: Black 3px double; border-right: Black 3px double; border-bottom: Black 3px double; padding: 5pt">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10.98pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 7.98pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 2px dotted; border-right: Black 2px dotted; border-left: Black 2px dotted; padding-left: 5pt; padding-top: 5pt; text-align: justify; padding-right: 5pt"><B>To vote your Quest Diagnostics Incorporated shares, you can attend the Annual Meeting of Stockholders and vote during the meeting or you can:</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 69%">&nbsp;</TD>
    <TD STYLE="border-left: Black 2px dotted; padding-left: 5pt; width: 3%"><B>1.</B></TD>
    <TD STYLE="border-right: Black 2px dotted; padding-right: 5pt; width: 28%"><B>Go to <U>www.ViewMaterial.com/DGX</U></B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-left: Black 2px dotted; padding-left: 5pt"><B>2.</B></TD>
    <TD STYLE="border-right: Black 2px dotted; padding-right: 5pt; padding-left: 8pt; text-indent: -8pt"><B>Click on the icon to submit a proxy for your shares.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-left: Black 2px dotted; padding-left: 5pt"><B>3.</B></TD>
    <TD STYLE="border-right: Black 2px dotted; padding-right: 5pt; padding-left: 8pt; text-indent: -8pt"><B>Enter the 11 digit control number (located by the arrow in the box above).</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-left: Black 2px dotted; padding-left: 5pt"><B>4.</B></TD>
    <TD STYLE="border-right: Black 2px dotted; padding-right: 5pt; padding-left: 8pt; text-indent: -8pt"><B>Follow the simple instructions to record your voting instructions.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-left: Black 2px dotted; padding: 5pt; border-bottom: Black 2px dotted; text-align: center; border-right: Black 2px dotted"><B>You are able to submit a proxy online until <FONT STYLE="white-space:nowrap">11:59 p.m. (EDT)</FONT> on May 16, 2023.</B></TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>x1_c105212x2x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 x1_c105212x2x1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  S )T# 2(  A$! Q$!_\0
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M??ML6O\ P3V_8>^.O[4ZZ3I7B3Q3X&T32M&^&OA36IY(=,\2_%'QSKVF>#?
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MR%]I\?B/1[BW\2>!O '@2Z\)?#GP'X)UO3-)C\.WVI2R?V1XE^W5^QI\3O\
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MLM(E\1ZCX6OK/2?&UWHME';V.D7GCG1/$MWI6GV5CIUA+;V%I;VR>A?L4_\
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M'Q+JL?C.V_N' P3SD9ZC@,!DCCIU)Y'7KR*"=8OS^^QR_@;P9X;^''@KP?\
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M++QG\,(O@YXS\%_!CX5?$7]F7Q/X*FT'PDOBZ#X^?$>[^&WQ*^(?PC\2ZO\
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M)#:>/O&OQ@^*OA]1%*DT9;PI\4/B+XP\+R.CHN))-'>0(#%N\IF0E% 'ZL>
MOA]X!^%GA72? GPQ\#^#_AQX'T"+[)H7@WP%X9T3P?X4T6U496VTGP[X>L=.
MT?3H 1Q%9V<*#LM=E110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_
!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
